First AD

Second AD

Melanoma & Skin Cancer

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Data Updates in the Treatment of Resectable Cutaneous Squamous Cell Carcinoma (CSCC)

Peer Exchange

Moffitt Cancer Center

Cancer Centers

Partner

Florida Cancer Specialists & Research Institute

Oncology Network Providers

UPMC Hillman Cancer Center

Expert panelists share their perspectives on best strategies to risk stratify patients diagnosed with cutaneous squamous cell carcinoma. 

Optimal Risk Stratification in Patients With Cutaneous Squamous Cell Carcinoma 

Cutaneous Squamous Cell Carcinoma: Incidence and Risk Factors 

Available Staging Systems for Cutaneous Squamous Cell Carcinoma 

Defining Resectability in CSCC

Staging and Risk Stratification’s Impact on Treatment Approach in CSCC

Real World Experience With Resectable Cutaneous Squamous Cell Carcinoma

Evolving Treatment Paradigm of Resectable CSCC

Clinical Experience With Neoadjuvant IO Therapy in Melanoma 

Lessons Learned in Other Cancers and Suggested Endpoints in Future Trials 

Neoadjuvant IO Therapy Trials in Resectable CSCC and Cemiplimab Data Updates

CSCC: Translating Cemiplimab Data Into Practice 

Other Emerging Treatment Modalities in Cutaneous Squamous Cell Carcinoma 

Best Practices in Multidisciplinary Care for CSCC

CSCC: Escalating Therapy for High-risk Patients 

Practical Advice on the Evolving Management of CSCC